Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov .
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov .

Dr. Natalia Komissarova

Dr. Natalia Komissarova

Scientific Review Officer



Biography

Division:
Division of Translational and Clinical Sciences DTCS
Review Branch:
Integrative Vascular Biology and Hematology IVBH
Study Section:
Atherosclerosis and Vascular Inflammation AVI

Dr. Natalia Komissarova spent more than 15 years at the intramural program of the NIH; prior to that, she worked in the Public Health Research Institute, New York. She received her Ph.D. in molecular biology from the Institute of Molecular Genetics and Moscow State University (Russia). Dr. Komissarova’s research focused on fundamental processes of transcription regulation in bacteriophage, bacteria, yeast, and mammals. She revealed important aspects of the structure of the transcription elongation complex of RNA polymerase and elucidated the mechanisms of transcription pausing and termination. She also studied epigenetic control of higher-order chromatin assembly and processes regulating major histocompatibility complex class I genes. Her research resulted in a paradigm shifting discovery of the mechanism of transcriptional arrest shown to be involved in developmental and homeostatic genetic programs.

 

Last updated: 07/11/2025 13:16